<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[52, 61] Mean change of quantitative muscle strength testing sum scores<br>[68, 74] Quantitative muscle strength testing sum scores<br>[110, 124] manual muscle testing sum scores, activity scale scores and patients' own assessments<br>[130, 134] Serum creatine kinase activity<br>[150, 154] progression of muscle weakness<br>[156, 161] serum creatine kinase activity.<br></td>
<td width=33%>
[52, 61] Mean change of quantitative muscle strength testing sum scores<br>[68, 74] Quantitative muscle strength testing sum scores<br>[110, 124] manual muscle testing sum scores, activity scale scores and patients' own assessments<br>[130, 134] Serum creatine kinase activity<br>[150, 154] progression of muscle weakness<br>[156, 161] serum creatine kinase activity.<br></td>
<td width=33%>
[5, 8] inclusion body myositis<br>[29, 31] disease progression<br>[52, 61] Mean change of quantitative muscle strength testing sum scores<br>[68, 75] Quantitative muscle strength testing sum scores declined<br>[107, 124] no differences in manual muscle testing sum scores, activity scale scores and patients' own assessments<br>[130, 136] Serum creatine kinase activity decreased significantly<br>[150, 161] progression of muscle weakness but decreased serum creatine kinase activity.<br></td>
</tr>
